-
Wizards choose teenage talent Dybantsa with No.1 pick in NBA Draft
-
Golden Boot battle steals the show at World Cup
-
Tuchel insists England remain on course at World Cup despite Ghana draw
-
Red or green? For Brazil, the politics of World Cup kits matter
-
Bellingham rues England's 'second game fever' after Ghana draw
-
US Congress passes landmark housing affordability bill
-
Meta offers lower cost glasses as wearables competition heats up
-
Dream job: US soccer fans paid to watch every World Cup game
-
England left frustrated by Ghana in World Cup draw
-
Europe wilts under record heat as AC sales soar
-
Grieving Deschamps to miss France's final World Cup group game
-
Rubio rejects Iran tolls on Hormuz as deal strains multiply
-
Two-goal Ronaldo delights in silencing critics after 'attacks'
-
Cubans bid farewell to revolution hero Valdes
-
Morocco squad 'supporting' Hakimi despite impending rape trial
-
Ronaldo delights in silencing 'attacks' after making World Cup history
-
Airbus to inspect 16 A380s after cracks found on plane wings
-
'Paris in this heat is awful': Tourists change plans as sites close early
-
Bolivian government says cleared all protest roadblocks
-
'I'm back': Ronaldo scores at sixth World Cup as Portugal run riot
-
France has hottest-ever day as 'unbearable' heatwave keeps scorching Europe
-
US TV news host begs for info after kidnap note says mother is dead
-
Ronaldo double fires Portugal, England eye last 32
-
Ronaldo scores at sixth World Cup as Portugal run riot
-
Hollywood powerhouses bring AI fight to Europe
-
Portugal's Ronaldo first man to score at six World Cups
-
What is driving Europe's heatwave?
-
Rubio says US will not accept Iranian tolls on Hormuz
-
Spain's Oyarzabal happy to play through pain at World Cup
-
Marco Rubio in Gulf to reassure allies hit hard by Mideast war
-
US Supreme Court rules against man whose dreadlocks were cut off in prison
-
American Michele Kang agrees deal to buy French club Lyon
-
UN to begin evacuating stranded Mideast sailors after US-Iran talks
-
French farmers suffer arid crops, heat-stricken animals
-
Tech drags down world stocks, oil dips on supply hopes
-
Scorching heat shuts Paris landmarks early as France swelters
-
Shootout traps tourists at Rio sunrise lookout
-
Ipswich hire Gary O'Neil as manager
-
Heatwave sparks health warnings across Europe
-
Lake wins Wales captaincy race ahead of Morgan
-
Hundreds of schools close as UK braces for record-breaking heatwave
-
Tech names drag down world stocks, oil dips on supply hopes
-
Starmer vows 'orderly' transition as Labour MPs mull bid to be PM
-
Reports of Dupont inclusion in France squad 'bordering on annoying' says Galthie
-
ACTIVIST SHAREHOLDER FILES SCHEDULE 13D IN EQUUS TOTAL RETURN, INC.
-
England coach McCullum denies rift with 'good friend' Stokes
-
Europe: the world's fastest-warming continent
-
Taliban officials hold EU migration talks in Brussels
-
Gennaro Gattuso returns to coaching with Lazio after Italy debacle
-
Kenya halts US Ebola facility: health minister tells court
Charlie's Holdings (OTCQB:CHUC) Selected for FDA Premarket Tobacco Product Applications Meeting
Charlie's Director, Dr. Ed Carmines, an expert on regulatory submissions and product safety, will discuss Pharmacological Profiles at the prestigious FDA roundtable.
COSTA MESA, CA / ACCESS Newswire / February 10, 2026 / Charlie's Holdings, Inc.(OTCQB:CHUC) ("Charlie's" or the "Company"), an industry leader in the premium vapor products space, today reported that the Center for Tobacco Products of the U.S. Food and Drug Administration ("FDA") selected Charlie's Board member, Ed Carmines, PhD, to serve as a panelist for the Roundtable on Premarket Tobacco Product Application ("PMTA") Submissions for Electronic Nicotine Delivery Systems ("ENDS") that will be held at 9:00am (Eastern Time) today at FDA Headquarters in Silver Spring, Maryland.
Dr. Ed Carmines, Chief Scientific Officer of Chemular, Inc, and independent Board Member of Charlie's Holdings, is a world-renowned expert in the technical aspects of all types of e-cigarettes, oral tobacco, tobacco-free products, cigars, and cigarettes. Having successfully navigated the FDA's Substantial Equivalence, PMTA, and Modified Risk Tobacco Product Application ("MRTPA") pathways for literally thousands of products, Dr. Carmines spearheaded development and licensing of proprietary technology to enable Charlie's to offer a controlled e-cigarette device that is made operable only upon activation by an age-verified adult consumer.
By launching this strategic initiative, Charlie's has endeavored to make the Company's PACHA™ disposable e-cigarette products the first flavored e-cigarettes able to be sold legally in the United States.
During today's FDA roundtable, Dr. Carmines will discuss pharmacokinetic studies around Charlie's PACHA products as well as studies of adult benefits related to flavored ENDS products that could result in Charlie's becoming the first Company to demonstrate to the FDA that age-gated flavored vape products are indeed 'appropriate for the protection of public health.'
The FDA roundtable discussion will be available for viewing online.
For more information about providing comments, orally or in writing, please see the Federal Register notice.
About Charlie's Holdings, Inc.
Charlie's Holdings, Inc. (OTCQB:CHUC) is an industry leader in the premium vapor products space. The Company's products are sold around the world to select distributors, specialty retailers, and third-party online resellers through subsidiary company Charlie's Chalk Dust, LLC has developed an extensive portfolio of brand styles, flavor profiles, and innovative product formats.
For additional information, please visit Charlie's corporate website at: Chuc.comand the Company's branded online websites: sbxvape.com, CharliesChalkDust.com, enjoypachamama.com, and Pacha.co.
Safe Harbor Statement
This press release contains "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to statements regarding the Company's overall business, existing and anticipated markets and expectations regarding future sales and expenses. Words such as "expect," "anticipate," "should," "believe," "target," "project," "goals," "estimate," "potential," "predict," "may," "will," "could," "intend," variations of these terms or the negative of these terms, and similar expressions, are intended to identify these forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that are beyond the Company's control. The Company's actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including but not limited to: the Company's ongoing ability to quote its shares on the OTCQB; whether the Company will meet the requirements to up-list to a national securities exchange in the future; the Company's ability to successfully increase sales and enter new markets; whether the Company's PMTA's for its nicotine-containing products will be authorized by the FDA, and the FDA's decisions with respect to the Company's future PMTA's for nicotine products; the Company's ability to manufacture and produce products for its customers; the Company's ability to formulate new products; the acceptance of existing and future products; the complexity, expense and time associated with compliance with government rules and regulations affecting nicotine, synthetic nicotine, products containing nicotine substitutes, and products containing cannabidiol; litigation risks from the use of the Company's products; risks of government regulations; the impact of competitive products; and the Company's ability to maintain and enhance its brands, as well as other risk factors included in the Company's most recent quarterly report on Form 10-Q, annual report on Form 10-K, and other SEC filings. These forward-looking statements are made as of the date of this press release and are based on current expectations, estimates, forecasts and projections as well as the beliefs and assumptions of management. Except as required by law, the Company undertakes no duty or obligation to update any forward-looking statements contained in this release as a result of new information, future events or changes in its expectations.
Investors Contact:
[email protected]
Phone: 949-570-0691
SOURCE: Charlie's Holdings, Inc.
View the original press release on ACCESS Newswire
M.O.Allen--AT